Insufficient scRNA-seq data for expression of CXCL9 at tissue level.
Tissue | GTEx Coverage  | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 97% | 1320.26 | 563 / 578 | 73% | 109.53 | 840 / 1155 |
| breast | 69% | 317.45 | 318 / 459 | 67% | 139.74 | 747 / 1118 |
| thymus | 92% | 1020.51 | 603 / 653 | 38% | 52.59 | 231 / 605 |
| kidney | 78% | 306.39 | 69 / 89 | 50% | 63.48 | 455 / 901 |
| intestine | 55% | 378.28 | 528 / 966 | 54% | 54.11 | 283 / 527 |
| stomach | 43% | 212.69 | 154 / 359 | 59% | 114.79 | 169 / 286 |
| spleen | 100% | 578.63 | 241 / 241 | 0% | 0 | 0 / 0 |
| prostate | 67% | 319.00 | 165 / 245 | 32% | 18.44 | 159 / 502 |
| bladder | 52% | 92.57 | 11 / 21 | 46% | 67.13 | 232 / 504 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 1220.41 | 28 / 29 |
| esophagus | 39% | 147.33 | 563 / 1445 | 57% | 74.45 | 104 / 183 |
| liver | 65% | 121.42 | 146 / 226 | 31% | 33.79 | 126 / 406 |
| skin | 29% | 113.93 | 528 / 1809 | 64% | 159.53 | 301 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 249.12 | 40 / 45 |
| uterus | 33% | 86.16 | 56 / 170 | 52% | 88.03 | 240 / 459 |
| adipose | 83% | 544.28 | 999 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 74% | 295.57 | 987 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 21% | 48.29 | 37 / 180 | 40% | 35.56 | 174 / 430 |
| pancreas | 21% | 37.09 | 68 / 328 | 39% | 42.37 | 69 / 178 |
| heart | 54% | 128.61 | 467 / 861 | 0% | 0 | 0 / 0 |
| muscle | 29% | 54.35 | 235 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 23% | 24.08 | 60 / 258 | 5% | 2.61 | 12 / 230 |
| peripheral blood | 19% | 58.22 | 176 / 929 | 0% | 0 | 0 / 0 |
| brain | 7% | 27.55 | 197 / 2642 | 4% | 3.34 | 25 / 705 |
| eye | 0% | 0 | 0 / 0 | 10% | 8.63 | 8 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006954 | Biological process | inflammatory response |
| GO_0007165 | Biological process | signal transduction |
| GO_0051607 | Biological process | defense response to virus |
| GO_0030593 | Biological process | neutrophil chemotaxis |
| GO_0045663 | Biological process | positive regulation of myoblast differentiation |
| GO_0006935 | Biological process | chemotaxis |
| GO_0006968 | Biological process | cellular defense response |
| GO_0007267 | Biological process | cell-cell signaling |
| GO_1901741 | Biological process | positive regulation of myoblast fusion |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0070098 | Biological process | chemokine-mediated signaling pathway |
| GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO_0071222 | Biological process | cellular response to lipopolysaccharide |
| GO_0051281 | Biological process | positive regulation of release of sequestered calcium ion into cytosol |
| GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO_0042127 | Biological process | regulation of cell population proliferation |
| GO_0006952 | Biological process | defense response |
| GO_0005615 | Cellular component | extracellular space |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0005576 | Cellular component | extracellular region |
| GO_0048248 | Molecular function | CXCR3 chemokine receptor binding |
| GO_0008009 | Molecular function | chemokine activity |
| GO_0045236 | Molecular function | CXCR chemokine receptor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0005125 | Molecular function | cytokine activity |
| Gene name | CXCL9 |
| Protein name | C-X-C motif chemokine 9 (Gamma-interferon-induced monokine) (Monokine induced by interferon-gamma) (HuMIG) (MIG) (Small-inducible cytokine B9) Alternative protein CXCL9 |
| Synonyms | MIG SCYB9 CMK |
| Description | FUNCTION: Cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response. Chemotactic for activated T-cells. Binds to CXCR3. |
| Accessions | ENST00000264888.6 L8E8X0 Q07325 |
